Paclitaxel (protein bound particles) for Injectable suspension

Paclitaxel Protein Bound Particles for Injectable Suspension (Albumin Bound) (Lyophilized):

• Medication Type: Paclitaxel protein-bound particles are administered via injection.
• Purpose: This formulation is used to treat various cancers, including breast, lung, and pancreatic cancer.
• Composition: It consists of paclitaxel, a chemotherapy medication, bound to albumin, a protein found in blood.
• Mechanism of Action: Paclitaxel disrupts the function of cancer cells by inhibiting their ability to divide and grow, while the albumin helps to deliver the medication to the tumor site.
• Dosage: The dosage and frequency of administration are determined by a healthcare provider based on factors such as the type and stage of cancer, as well as the patient’s overall health.
• Administration: Administered intravenously after reconstitution with a compatible diluent.
• Side Effects: Common side effects may include hair loss, nausea, vomiting, fatigue, and decreased blood cell counts.
• Precautions: Patients should be monitored closely for signs of allergic reactions and bone marrow suppression during treatment.
• Interactions: Paclitaxel may interact with other medications, so it’s important to inform the healthcare provider about all medications being taken.